-
Mashup Score: 1First U.S. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study - 10 month(s) ago
July 11, 2023 — FIRE1 announced that the first U.S. patients have been successfully implanted with its FIRE1 System for remote heart failure monitoring in an Early Feasibility Study. The study will assess FIRE1’s novel solution to improve outcomes for heart failure patients. The first patient was implanted at Austin Heart, Texas, where Kunjan Bhatt, MD, leads the study as Principal Investigator…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Sequana Medical Announces First Patient Enrolled in MOJAVE - 10 month(s) ago
July 10, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces that the first patient has been enrolled in its MOJAVE study. MOJAVE, a randomized controlled Phase 1/2a study in the US, will evaluate the safety and efficacy of the Company’s second-generation DSR product (DSR 2.0) in diuretic-resistant chronic heart failure…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @SequanaMed #MOJAVE, a randomized controlled Phase 1/2a study in the US, will evaluate the safety and efficacy of the company’s second-generation #DSR product in diuretic-resistant chronic #heartfailure patients with persistent congestion: https://t.co/P4ructfqhq
-
-
Mashup Score: 0Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care - 10 month(s) ago
July 11, 2023 — Hyperfine, Inc., the groundbreaking medical device company that created the Swoop system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, has announced the commencement of an international, multi-site observational study, ACTION PMR (ACuTe Ischemic strOke detectioN with Portable MR). To support its acute stroke care initiatives, Hyperfine Inc. has…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @Hyperfine Hyperfine announced the commencement of an international, multi-site observational #study, #ACTION_PMR (ACuTe Ischemic strOke detectioN with Portable #MR): https://t.co/Vg0qp3Pj8k
-
-
Mashup Score: 0First U.S. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study - 10 month(s) ago
July 11, 2023 — FIRE1 announced that the first U.S. patients have been successfully implanted with its FIRE1 System for remote heart failure monitoring in an Early Feasibility Study. The study will assess FIRE1’s novel solution to improve outcomes for heart failure patients. The first patient was implanted at Austin Heart, Texas, where Kunjan Bhatt, MD, leads the study as Principal Investigator…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor #FIRE1 announced the start of the first US #clinicalstudy of its remote #heartfailure monitoring system, designed to provide unique insights to the care team and alert to deteriorating patient conditions for the almost 10M Americans with #HF: https://t.co/Ut9InXoqW5
-
-
Mashup Score: 0Adona Medical’s Next-Generation Heart Failure Management Platform Showcased at CSI Frankfurt 2023 Conference - 10 month(s) ago
July 10, 2023 — Adona Medical, a Shifamed portfolio company that aims to deliver advanced interatrial shunting and hemodynamic monitoring systems for heart failure, announced today that its next-generation heart failure management platform was featured at the CSI Frankfurt 2023 conference. Brian Fahey, Co-Founder and Chief Executive Officer of Adona Medical, introduced the company’s developing…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @AdonaMedical The #Adona heart failure management platform includes an adjustable #interatrial #shunt with integrated #bi_atrial pressure monitoring: https://t.co/7KDYZgW8vY
-
-
Mashup Score: 0FDA Approves Expanded Indication for Leqvio - 10 month(s) ago
July 10, 2023 — Novartis announced that the US Food and Drug Administration (FDA) has approved a label update for Leqvio (inclisiran) to enable earlier use in patients with elevated LDL-C who have an increased risk of heart disease, as an adjunct to diet and statin therapy1. This patient population includes those who have comorbidities such as hypertension and diabetes and have not yet had a…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @NovartisOncMed #Leqvio can now be used earlier in #LDL_C treatment as an adjunct to diet and #statintherapy for patients who have not had a ##cardiovascular event but are at an increased risk of heart: https://t.co/erQvs56Oc6
-
-
Mashup Score: 0Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease Unlikely to Increase Risk of Mortality - 10 month(s) ago
July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information associated with paclitaxel-coated devices used to treat peripheral arterial disease (PAD). Based on the FDA’s review of the totality of the available data and analyses, it has determined that the data does not support an excess mortality risk for paclitaxel-coated devices. The…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @FDADeviceInfo The U.S. Food and Drug Administration (#FDA) has issued a Letter to #HealthCare Providers about updated information associated with #paclitaxel-coated devices used to treat #peripheral #arterial #disease (#PAD): https://t.co/1owQZPwQD0
-
-
Mashup Score: 0A Model for Africa: Côte d’Ivoire Health Ministry Announces New Initiative to Become Self-Sufficient in Pediatric Cardiology Surgery - 10 month(s) ago
July 7, 2023 — Launched by Mitrelli Group, Menomadin Foundation, Save a Child’s Heart, Côte d’Ivoire Health Ministry and Abidjan Institute of Cardiology; Côte d’Ivoire Minister of Health: “Health-independence is a national strategic priority, and this project is a major step on the road to that vital goal.” ; Taking part in the project: Mitrelli’ s health subsidiary Promed International…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @MitrelliGroup @SACHYL The #MitrelliGroup, the #MenomadinFoundation, Save a Child’s Heart, and the #Côte_dIvoireHealthMinistry, formed innitative to build national effort to treat more children: https://t.co/TRG4cB5OHO
-
-
Mashup Score: 0Reduced Levels of FKBP5 Promote Atrial Fibrillation - 10 month(s) ago
July 7, 2023 — Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs when the heart beats so fast that the upper chambers of the heart quiver. This irregular heartbeat can lead to severe conditions, including heart failure, dementia and a fivefold increase in the risk of stroke. AFib affects more than 33.5 million people worldwide, and its…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @bcmhouston At Baylor College of Medicine, Dr. #NaLi’s lab and her colleagues have been investigating #AFib’s underpinnings and identified key molecules and associated processes contributing to the development of persistent AFib forms: https://t.co/c5BtZT2SPc
-
-
Mashup Score: 0CMS Establishes HCPCS code for Ultromics EchoGo Heart Failure - 10 month(s) ago
July 7, 2023 — Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and its phenotypes, announced today the assignment of a new outpatient code by the Centers for Medicare and Medicaid Services (CMS), for its flagship product, EchoGo Heart Failure. CMS established a new HCPCS code (C9786) in the Hospital Outpatient Prospective Payment System…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @ultromics Ultromics announced the assignment of a new outpatient code by the Centers for Medicare and Medicaid Services (#CMS), for its flagship product, #EchoGo #HeartFailure: https://t.co/Ym7s0OPpOk
-
First U.S. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study https://t.co/w6NHBV3qfN